Lee Ainslie's WVE Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 9.28 M shares of Wave Life Sciences Ltd. (WVE) worth $157.76 M, representing 1.69% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in WVE, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2021, adding 2.4 M shares. Largest reduction occurred in Q4 2024, reducing 1.79 M shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Wave Life Sciences (WVE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Wave Life Sciences (WVE) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +888,381 | Add 10.59% | 9.28 M | $17.00 |
| Q3 2025 | +130,173 | Add 1.58% | 8.39 M | $7.32 |
| Q1 2025 | +441 | Add 0.01% | 8.26 M | $8.08 |
| Q4 2024 | -1.79 M | Reduce 17.78% | 8.26 M | $12.37 |
| Q3 2024 | +2.38 M | Add 31.01% | 10.05 M | $8.20 |
| Q2 2024 | -18,718 | Reduce 0.24% | 7.67 M | $4.99 |
| Q1 2024 | -759,725 | Reduce 8.99% | 7.69 M | $6.17 |
| Q4 2023 | +1.85 M | Add 28.11% | 8.45 M | $5.05 |
| Q3 2023 | -2,459 | Reduce 0.04% | 6.59 M | $5.75 |
| Q1 2023 | -500,886 | Reduce 7.06% | 6.6 M | $4.33 |
| Q4 2022 | -707,555 | Reduce 9.07% | 7.1 M | $7.00 |
| Q2 2022 | +2.21 M | Add 39.54% | 7.81 M | $3.25 |
| Q4 2021 | +2.4 M | Add 75.16% | 5.59 M | $3.14 |
| Q3 2021 | +105,258 | Add 3.41% | 3.19 M | $4.90 |
| Q2 2021 | +4,930 | Add 0.16% | 3.09 M | $6.66 |
| Q1 2021 | +3.08 M | New Buy | 3.08 M | $5.61 |
Lee Ainslie's Wave Life Sciences Investment FAQs
Lee Ainslie first purchased Wave Life Sciences Ltd. (WVE) in Q1 2021, acquiring 3,083,201 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Wave Life Sciences Ltd. (WVE) for 20 quarters since Q1 2021.
Lee Ainslie's largest addition to Wave Life Sciences Ltd. (WVE) was in Q1 2021, adding 3,083,201 shares worth $17.3 M.
According to the latest 13F filing for Q4 2025, Lee Ainslie's firm, Maverick Capital LTD, owns 9,280,237 shares of Wave Life Sciences Ltd. (WVE), valued at approximately $157.76 M.
As of the Q4 2025 filing, Wave Life Sciences Ltd. (WVE) represents approximately 1.69% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Wave Life Sciences Ltd. (WVE) was 10,047,520 shares, as reported at the end of Q3 2024.